Deloitte acquires risk-based platform designed to address GxP requirements

By Maggie Lynch contact

- Last updated on GMT

(Image:Getty/BrianAJackson)
(Image:Getty/BrianAJackson)

Related tags: Risk management, Good clinical practice, Life sciences companies, validation

Deloitte’s acquisition of QSpace expands its IT quality and compliance solutions offering for life sciences firms, including contract research and manufacturing organizations.

Deloitte acquired QSpace, a validation lifecycle management system (VLMS), on August 24, 2018 in an aim to expand its information technology (IT) and compliance solutions suite for life sciences organizations.

The company acquired the risk-based platform – designed to address IT quality and compliance, computerized system validation, and Good X Practice (GxP) requirements – from the India-based pharmaceutical manufacturer Archimedis Healthcare Private Limited.

According to Chuck Saia, CEO, Deloitte Risk and Financial Advisory at Deloitte subsidiary Deloitte & Touche, the acquisition brings a “leaner and standardized VLM​S” to clients to provide IT quality and compliance to pharmaceutical, medical device, contract research, contract manufacturing, and distribution sectors.

According to the company, the platform provides real-time insights into performance indicators across validation lifecycle and digitizes end-to-end validation processes. Sirkanth Narayan the managing director of Deloitte Risk and Financial Advisory told us that Validation Lifecycle managment systems (VLMS) help reduce risks associated with manual execution through digitizing validation processes. The system is, "Something particularly helpful to multi-national organizations,"​ she added. 

"We know executives at leading organizations in the pharmaceutical, medical device, contract research, contract manufacturing and distribution sectors want to improve IT quality and compliance efforts as part of broader compliance modernization initiatives,”​ said Monica O'Reilly​, Deloitte Risk and Financial Advisory​ principal and leader of its regulatory and operational risk practice​.

“QSpace enables that transformation for IT operations, compliance and risk management, while also freeing up resources for organizations to focus more on the business of innovating for the benefit of customers and patients,”​ she said in the press release.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Products

View more

Webinars